Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1948 1
1950 2
1951 1
1952 2
1953 3
1954 3
1956 1
1957 1
1958 1
1961 4
1962 3
1963 21
1964 19
1965 28
1966 19
1967 19
1968 49
1969 42
1970 38
1971 33
1972 23
1973 31
1974 25
1975 33
1976 36
1977 48
1978 50
1979 52
1980 67
1981 79
1982 89
1983 94
1984 108
1985 91
1986 101
1987 97
1988 125
1989 162
1990 126
1991 148
1992 178
1993 183
1994 184
1995 213
1996 203
1997 212
1998 234
1999 275
2000 284
2001 285
2002 307
2003 332
2004 329
2005 383
2006 381
2007 436
2008 395
2009 416
2010 449
2011 477
2012 542
2013 594
2014 553
2015 600
2016 591
2017 668
2018 683
2019 688
2020 800
2021 831
2022 840
2023 782
2024 758
2025 808
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,098 results

Results by year

Filters applied: . Clear all
Page 1
Inebilizumab for Treatment of IgG4-Related Disease.
Stone JH, Khosroshahi A, Zhang W, Della Torre E, Okazaki K, Tanaka Y, Löhr JM, Schleinitz N, Dong L, Umehara H, Lanzillotta M, Wallace ZS, Ebbo M, Webster GJ, Martinez Valle F, Nayar MK, Perugino CA, Rebours V, Dong X, Wu Y, Li Q, Rampal N, Cimbora D, Culver EL; MITIGATE Trial Investigators. Stone JH, et al. Among authors: tanaka y. N Engl J Med. 2025 Mar 27;392(12):1168-1177. doi: 10.1056/NEJMoa2409712. Epub 2024 Nov 14. N Engl J Med. 2025. PMID: 39541094 Clinical Trial.
The microbiome diversifies long- to short-chain fatty acid-derived N-acyl lipids.
Mannochio-Russo H, Charron-Lamoureux V, van Faassen M, Lamichhane S, Gonçalves Nunes WD, Deleray V, Ayala AV, Tanaka Y, Patan A, Vittali K, Rajkumar P, El Abiead Y, Zhao HN, Gomes PWP, Mohanty I, Lee C, Sund A, Sharma M, Liu Y, Pattynama D, Walker GT, Norton GJ, Khatib L, Andalibi MS, Wang CX, Ellis RJ, Moore DJ, Iudicello JE, Franklin D Jr, Letendre S, Chin L, Walker C, Renwick S, Zemlin J, Meehan MJ, Song X, Kasper D, Burcham Z, Kim JJ, Kadakia S, Raffatellu M, Bode L, Chu H, Zengler K, Wang M, Siegel D, Knight R, Dorrestein PC. Mannochio-Russo H, et al. Among authors: tanaka y. Cell. 2025 Jul 24;188(15):4154-4169.e19. doi: 10.1016/j.cell.2025.05.015. Epub 2025 Jun 10. Cell. 2025. PMID: 40499541 Free PMC article.
Novel therapies in treatments of SLE.
Tanaka Y. Tanaka Y. Best Pract Res Clin Rheumatol. 2025 Oct 7:102101. doi: 10.1016/j.berh.2025.102101. Online ahead of print. Best Pract Res Clin Rheumatol. 2025. PMID: 41062351 Free article. Review.
Dual-Prep registry: atherectomy devices and intravascUlAr lithotripsy for the PREParation of heavily calcified coronary lesions registry.
Nakamura M, Kuriyama N, Tanaka Y, Yamazaki S, Kawasaki T, Muramatsu T, Kadota K, Ashikaga T, Takahashi A, Otsuji S, Ando K, Ishida M, Nakamura S, Ito Y, Iijima R, Nakazawa G, Shite J, Honye J, Ako J, Yokoi H, Kozuma K, Otake H, Masumura K, Yamada T, Sotomi Y. Nakamura M, et al. Among authors: tanaka y. Cardiovasc Interv Ther. 2025 Jul;40(3):553-564. doi: 10.1007/s12928-025-01130-9. Epub 2025 May 12. Cardiovasc Interv Ther. 2025. PMID: 40354027 Free PMC article.
EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update.
Fanouriakis A, Kostopoulou M, Anders HJ, Andersen J, Aringer M, Beresford MW, Doria A, Frangou E, Furie R, Gladman DD, Houssiau F, Karras A, Kouloumas M, Madenidou AV, Malvar A, Marinaki S, Mok CC, Moroni G, Parodis I, Rednic S, Santos CS, Scire CA, Smolen JS, Tamirou F, Tanaka Y, Teng YKO, Welin E, Bertsias G, Boumpas DT. Fanouriakis A, et al. Among authors: tanaka y. Ann Rheum Dis. 2025 Oct 16:S0003-4967(25)04412-7. doi: 10.1016/j.ard.2025.09.007. Online ahead of print. Ann Rheum Dis. 2025. PMID: 41107121 Free article.
Blood DNA virome associates with autoimmune diseases and COVID-19.
Sasa N, Kojima S, Koide R, Hasegawa T, Namkoong H, Hirota T, Watanabe R, Nakamura Y, Oguro-Igashira E, Ogawa K, Yata T, Sonehara K, Yamamoto K, Kishikawa T, Sakaue S, Edahiro R, Shirai Y, Maeda Y, Nii T, Chubachi S, Tanaka H, Yabukami H, Suzuki A, Nakajima K, Arase N, Okamoto T, Nishikawa R, Namba S, Naito T, Miyagawa I, Tanaka H, Ueno M, Ishitsuka Y, Furuta J, Kunimoto K, Kajihara I, Fukushima S, Miyachi H, Matsue H, Kamata M, Momose M, Bito T, Nagai H, Ikeda T, Horikawa T, Adachi A, Matsubara T, Ikumi K, Nishida E, Nakagawa I, Yagita-Sakamaki M, Yoshimura M, Ohshima S, Kinoshita M, Ito S, Arai T, Hirose M, Tanino Y, Nikaido T, Ichiwata T, Ohkouchi S, Hirano T, Takada T, Tazawa R, Morimoto K, Takaki M, Konno S, Suzuki M, Tomii K, Nakagawa A, Handa T, Tanizawa K, Ishii H, Ishida M, Kato T, Takeda N, Yokomura K, Matsui T, Uchida A, Inoue H, Imaizumi K, Goto Y, Kida H, Fujisawa T, Suda T, Yamada T, Satake Y, Ibata H, Saigusa M, Shirai T, Hizawa N, Nakata K; Japan COVID-19 Task Force; Imafuku S, Tada Y, Asano Y, Sato S, Nishigori C, Jinnin M, Ihn H, Asahina A, Saeki H, Kawamura T, Shimada S, Katayama I, Poisner HM, Mack TM, Bick AG, Higasa K, Okuno T, Mochizuki H, Ishii M, Koike R, K… See abstract for full author list ➔ Sasa N, et al. Among authors: tanaka y. Nat Genet. 2025 Jan;57(1):65-79. doi: 10.1038/s41588-024-02022-z. Epub 2025 Jan 3. Nat Genet. 2025. PMID: 39753770 Free PMC article.
Efficacy of nivolumab + ipilimumab ± chemotherapy versus pembrolizumab + chemotherapy in patients with PD-L1-negative non-small cell lung cancer (START001 PART-B): a multicenter retrospective observational study.
Nagano Y, Takahashi M, Sumi T, Yokoo K, Ishikawa T, Honjo O, Kudo S, Kondo S, Tanaka Y, Shioya M, Hashimoto M, Otsuka M, Sudo Y, Yanagi M, Yabe H, Nishikiori H, Yamazoe M, Asai Y, Fukataki Y, Hinotsu S, Chiba H. Nagano Y, et al. Among authors: tanaka y. Jpn J Clin Oncol. 2025 Aug 3;55(8):933-940. doi: 10.1093/jjco/hyaf073. Jpn J Clin Oncol. 2025. PMID: 40333938
Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AML.
Ikoma Y, Nakamura N, Kaneda Y, Takamori H, Seki T, Hiramoto N, Kitagawa J, Kanda J, Fujita K, Morishita T, Ochi Y, Chiba S, Sasaki N, Ichii M, Imada K, Watanabe M, Hishizawa M, Miyahara Y, Maesako Y, Tanaka Y, Oka S, Tsuji M, Yoshihara S, Mitani K, Ueda Y, Kitano T, Watanabe M, Sezaki N, Kondo T, Kasahara S, Takaori-Kondo A, Kanemura N, Ogawa S, Nannya Y. Ikoma Y, et al. Among authors: tanaka y. Leukemia. 2025 Jun;39(6):1362-1367. doi: 10.1038/s41375-025-02625-3. Epub 2025 Apr 21. Leukemia. 2025. PMID: 40259101 Free PMC article.
Intragenic viral silencer element regulates HTLV-1 latency via RUNX complex recruitment.
Sugata K, Rahman A, Niimura K, Monde K, Ueno T, Rajib SA, Takatori M, Sakhor W, Hossain MB, Sithi SN, Jahan MI, Matsuda K, Ueda M, Yamano Y, Ikeda T, Ueno T, Tsuchiya K, Tanaka Y, Tokunaga M, Maeda K, Utsunomiya A, Okuma K, Ono M, Satou Y. Sugata K, et al. Among authors: tanaka y. Nat Microbiol. 2025 Jun;10(6):1447-1462. doi: 10.1038/s41564-025-02006-7. Epub 2025 May 13. Nat Microbiol. 2025. PMID: 40360701 Free PMC article.
16,098 results
You have reached the last available page of results. Please see the User Guide for more information.